P069 Effect of Orkambi therapy on the lung microbiota in people with cystic fibrosis (PwCF) over the first 12 months of therapy (ROCK Study)

Yvonne Mccarthy

doi:10.1016/s1569-1993(23)00444-7

P069 Effect of Orkambi therapy on the lung microbiota in people with cystic fibrosis (PwCF) over the first 12 months of therapy (ROCK Study)

Yvonne Mccarthy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of Cystic Fibrosis
DOIs	https://doi.org/10.1016/s1569-1993(23)00444-7
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medicine
Cystic fibrosis
Sputum
Internal medicine
Gastroenterology
Pathology
Tuberculosis

Access to Document

10.1016/s1569-1993(23)00444-7

https://openalex.org/W4379981537Licence: CC BY-NC-ND

Cite this

@article{0792323fb3a24d77a0941abccf681090,

title = "P069 Effect of Orkambi therapy on the lung microbiota in people with cystic fibrosis (PwCF) over the first 12 months of therapy (ROCK Study)",

keywords = "Medicine, Cystic fibrosis, Sputum, Internal medicine, Gastroenterology, Pathology, Tuberculosis",

author = "Yvonne Mccarthy",

year = "2023",

doi = "10.1016/s1569-1993(23)00444-7",

language = "English",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - P069 Effect of Orkambi therapy on the lung microbiota in people with cystic fibrosis (PwCF) over the first 12 months of therapy (ROCK Study)

AU - Mccarthy, Yvonne

PY - 2023

Y1 - 2023

KW - Medicine

KW - Cystic fibrosis

KW - Sputum

KW - Internal medicine

KW - Gastroenterology

KW - Pathology

KW - Tuberculosis

U2 - 10.1016/s1569-1993(23)00444-7

DO - 10.1016/s1569-1993(23)00444-7

M3 - Article

SN - 1569-1993

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

ER -